P4HA1 and pancreatic ductal adenocarcinoma: In prostate cancer and pancreatic cancer, P4HA1 increased both on mRNA and protein levels, and P4HA1 expression was correlated with poor overall survival in pancreatic ductal adenocarcinoma patients 7, 11.